Frier Levitt is excited to share our most recent newsletter addressing crucial topics for Plan Sponsors. Within its pages, you’ll find important news and articles, tailored to help large employers, union groups and self-insured companies understand their drug benefit design.
- Jonathan Levitt Invited to Testify Before U.S. Senate Committee on Finance on the Impact of Pharmacy Benefit Managers on Patients and Taxpayers
- What Johnson & Johnson’s Lawsuit Against SaveOnSP Means for Drug Manufacturers and Plan Sponsors
- Pharmaceutical Executive: The Consolidated Appropriations Act and PBM Transparency
- Did the Inflation Reduction Act Spare PBMs?
- CAA Alters Landscape for Self-Funded Plans and Creates Opportunities
- CAA Alters Landscape for Self-Funded Plans and Creates Potential Pitfalls
- FTC Expands PBM Investigation to PBM-Owned Rebate Aggregators/GPOs
- Navigating New Laws: Employers’ Crucial Choice “To Sue or Not to Sue” Brokers, Third Party Administrators, and PBMs
Frier Levitt’s Plan Sponsor Practice Group provides a host of legal services to plan sponsors including reviewing and analyzing PBM contracts, negotiating and drafting PBM contracts, and auditing (and where necessary, litigating against) PBMs to verify that PBMs are abiding by the terms in the PBM contracts. Contact us to speak with an attorney.